FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

421752008: Gastro-resistant and prolonged-release oral capsule (dose form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3636030016 Gastro-resistant and prolonged-release oral capsule (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3636031017 Gastro-resistant and prolonged-release oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gastro-resistant and prolonged-release oral capsule (dose form) Is a Extended-release capsule false Inferred relationship Some
Gastro-resistant and prolonged-release oral capsule (dose form) Is a Prolonged-release oral capsule true Inferred relationship Some
Gastro-resistant and prolonged-release oral capsule (dose form) Has dose form administration method (attribute) A method of administration of a dose form by taking into the mouth and allowing to pass down the throat. true Inferred relationship Some
Gastro-resistant and prolonged-release oral capsule (dose form) Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. An intended site for a dose form that is for administration by swallowing. true Inferred relationship Some
Gastro-resistant and prolonged-release oral capsule (dose form) Has basic dose form (attribute) A solid single-dose form that is a shell made of gelatin or other substances. The contents of the shell may be a solid, semi-solid or liquid. true Inferred relationship Some
Gastro-resistant and prolonged-release oral capsule (dose form) Is a Gastro-resistant oral capsule (dose form) true Inferred relationship Some
Gastro-resistant and prolonged-release oral capsule (dose form) Has dose form transformation (attribute) No transformation true Inferred relationship Some
Gastro-resistant and prolonged-release oral capsule (dose form) Has dose form release characteristic (attribute) A release characteristic where a dose form displays both a slower release of some of the active substance(s) than that of a conventional-release dose form and also displays a delayed release of some of the active substance(s) within the same dose form. This may be achieved by a special formulation design, manufacturing process or other methods. true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely diclofenac sodium 75 milligram/1 each gastro-resistant and prolonged-release oral capsule (clinical drug) Has manufactured dose form True Gastro-resistant and prolonged-release oral capsule (dose form) Inferred relationship Some
Minocycline 100mg gastro-resistant and prolonged-release oral capsule Has manufactured dose form False Gastro-resistant and prolonged-release oral capsule (dose form) Inferred relationship Some
Dexrabeprazole sodium 10 mg and domperidone 30 mg gastro-resistant and prolonged-release oral capsule Has manufactured dose form True Gastro-resistant and prolonged-release oral capsule (dose form) Inferred relationship Some
Domperidone 30 mg and omeprazole 20 mg gastro-resistant and prolonged-release oral capsule Has manufactured dose form True Gastro-resistant and prolonged-release oral capsule (dose form) Inferred relationship Some
Itopride hydrochloride 150 mg and pantoprazole (as pantoprazole sodium) 40 mg gastro-resistant and prolonged-release oral capsule Has manufactured dose form True Gastro-resistant and prolonged-release oral capsule (dose form) Inferred relationship Some
Levosulpiride 75 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral capsule Has manufactured dose form True Gastro-resistant and prolonged-release oral capsule (dose form) Inferred relationship Some
Domperidone 30 mg and pantoprazole (as pantoprazole sodium) 40 mg gastro-resistant and prolonged-release oral capsule Has manufactured dose form True Gastro-resistant and prolonged-release oral capsule (dose form) Inferred relationship Some
Domperidone 30 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral capsule Has manufactured dose form True Gastro-resistant and prolonged-release oral capsule (dose form) Inferred relationship Some
Product containing precisely budesonide 3 milligram/1 each gastro-resistant and prolonged-release oral capsule (clinical drug) Has manufactured dose form True Gastro-resistant and prolonged-release oral capsule (dose form) Inferred relationship Some

This concept is not in any reference sets

Back to Start